A PHASE III PIVOTAL UMBRELLA TRIAL OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES (COLCHICINE RESISTANT FMF, HIDS/MKD AND TRAPS)
Annual European Congress of Rheumatology (EULAR), London, Canada, 8 - 11 June 2016, vol.75, pp.615-616, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 75
- Doi Number: 10.1136/annrheumdis-2016-eular.3881
- City: London
- Country: Canada
- Page Numbers: pp.615-616
- Hacettepe University Affiliated: Yes